One team, multiple talents

Senior Associate Consultant

Jai Bhakta

Jai joined Eradigm in April 2022 as a Senior Associate Consultant. Jai found himself joining the Eradigm team with his goal of advancing transformative therapies and technologies to patients and stakeholders across the healthcare and life sciences industries. Jai’s experience harmonizes breakthrough academic and commercial knowledge working across different sectors within the life sciences and healthcare industries. His knowledge spans across a variety of therapeutic areas and has expertise in medical devices and diagnostics.

Jai holds a Bachelor of Science and Arts from the University of Texas, where he was given the opportunity as a Research Assistant at the UT Clinical Neuroendocrinology Laboratory, receiving authorship on a late breaking abstract titled “Basal Salivary Testosterone Predicts Trait Anxiety in Healthy Men and Women”. His curiosity for advancing breakthrough research led him to Claremont College’s Keck Graduate Institute, where he received his Master of Business and Science with a concentration in Medical Devices and Diagnostics. At his time at Keck Graduate Institute, Jai served as a Graduate Student Consultant in Product Development for Nanosens Innovations, where he engaged in creating robust product profiles for NanoSens’ graphene-based dCas9-functionalized biosensor. Prior to completing his studies, Jai interned on City of Hope’s Research Business Development team. His time at City of Hope exposed him to internal development efforts, creative due diligence, out-licensing strategy, competitive intelligence, valuation, and City of Hope’s internal venture panels.

Prior to his role at Eradigm, Jai conducted global competitive intelligence at Decisive, partnering with top 20 Big Pharma companies spanning across therapeutic areas such as Oncology, Dermatology, Women’s Health, and Rare Diseases. He provided expansive due diligence and primary research analysis to B-Suite and C-Suite level executive teams.

 In his free time Jai likes to spend time with family and friends, draw, paint, produce & listen to music, cook a variety of cuisines, weight-train, and watch basketball and football (NCAA and Professional). 

Senior Associate Consultant

Michelle Saylor

Focus Therapy Area: Oncology, Neurodegenerative Diseases, Ophthalmology

Specialist Expertise: Diagnostics, Precision Medicine, Coverage and Reimbursement  

Education: Bachelor of Science from Brandeis University, with a concentration in Biology

What is your focus at Eradigm: My focus area at Eradigm is primarily market access which consists of elements that include commercial strategy and competitor and historic analysis. I work with a variety of stakeholders, industry giants to start-ups, that span across therapeutic areas.

What is your specialist expertise and what types of projects do you work on? I have both breadth and depth experience in multiple therapeutic areas that span from orphan drugs and rare diseases to more common spaces such as cancers and cardiovascular events. I assess market readiness through extensive research and perform additional analyses based on pricing, current coverage landscapes and competitive intelligence. Regardless of business questions or disease space, I always aim to deliver high-quality and solution-oriented work.

What did you do before Eradigm? Prior to Eradigm, I worked for a boutique healthcare consulting firm in Boston, MA. There, my focus was primarily commercial strategy, market access, and pricing and reimbursement.

What are your passions outside of work? I love all things having to do with food: cooking, eating, tasting, and enjoying meals with friends and family. I travel quite a bit and am working my way down my ever-expanding list of places to see. When I’m not travelling or munching, I like to read, watch documentaries, and play with my dogs.

Senior Associate Consultant

Cooper Grayson

Cooper holds a bachelor’s degree in Biology, Health and Society from the University of Michigan, with a focus in public health, and the ethics of health and medicine. During his studies, he also minored in the Sociology of Health and Medicine and also participated in various student organizations including the Health Policy Student Association and the Pre-Public Health Association.  

Together, this has added to Cooper’s interests in the multitude of aspects within pharma and healthcare that go into changing the lives of patients for the better, who has found consulting as a method to gain knowledge and experience in these unique spaces. 

As part of his career and prior to Eradigm, Cooper spent time working with a Top10 pharmaceutical company functioning as a project manager on a handful of their global medical teams, most recently in the area of immuno-oncology GI & liver cancer. Cooper has gained experience and expertise in pharmaceutical project management, launch planning & development, secondary research and market access. Cooper has also had hands-on experience providing secondary research for a biotech company specializing in leveraging proprietary computational systems like A.I., to accelerate the development of novel drug alternatives for life threatening diseases.

Outside of work, Cooper is an avid sports fan, with his favorite teams being the New York Mets, Jets, Rangers, Brooklyn Nets, Tottenham Hotspur, and all University of Michigan athletic teams. Cooper also enjoys standup comedy and is a true seeker of new cuisines. In his free time, Cooper likes to explore his home of New York City, exercise / play sports, listen to music, and discover new restaurants. 

Senior Associate Consultant

Hisham Nachabe

Hisham joined Eradigm in June 2022 as a senior associate consultant. He brings to Eradigm a breadth of scientific and consulting experience having completed an ORISE research fellowship at the Walter Reed Institute of Army Research, before channelling his interest in life sciences and enthusiasm for pharma into market access strategy and financial analysis.

With a BSc in Biology and Biotechnology Hisham has a passion for breakthrough science and emerging therapeutics. He has combined this passion with robust secondary research to generate impactful strategy solutions for various clients around the globe. At Eradigm, Hisham’s goal is to help develop a roadmap of success, built on market research, primary engagement, and a deep understanding of financial models. Strong communication is a cornerstone of Hisham’s approach, with contributions to a number of published papers and reports, he enjoys building relationships with Key Opinion leaders to providecritical perspectives that shape his work. His previous projects have spanned various therapeutic areas with his expertise focusing on oncology, neurology, medical devices, and public health.

Outside of work, Hasham loves personal fitness with a particular interest in weight training. He also enjoys outdoor pursuits such as tennis, hiking, kayaking, and camping at the weekends (when the weather permits). In his downtime, Hisham’s a keen reader with a distinct interest in philosophy.

Senior Associate Consultant

Sneha Chatterjee

Sneha joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her experience in infectious diseases research and a strive for contributing to global healthcare enhancement.

Sneha worked in consulting projects spanning therapeutic areas such as oncology, infectious diseases, haematology and rare diseases, and devices. She was involved in conducting competitive intelligence for multiple projects delivered on market assessment, data analytics, KOL profiling and social media analytics geographies including US, EU, LATAM and APAC markets. She was responsible for project management and driving multiple strategic intelligence engagements for year-long tracker projects to help clients understand and strategize their competition. She has also gained profound experience in collecting comprehensive market, competitor and stakeholder evidence through desk-based interviewing and elicitation; conducting research and analysing industry trends and data, create competitive landscape to understand the healthcare scenario, and comprehend reimbursement policies in global pharmaceutical market.

By qualification, Sneha is a medical microbiologist and obtained her PhD in infectious diseases with her research in the in overlapping fields of immunology and host-pathogen interaction, from the Medical University of Innsbruck, Austria. Her thesis decoded the role of Shiga toxin produced by Enterohemorrhagic E. coli (EHEC) in Haemolytic Uremic Syndrome (HUS). Prior to that, she secured her masters in Applied Microbiology from the VIT University, India, and bachelors in Microbiology (Honours) from the University of Delhi, India.

Outside of work, Sneha loves to travel and enjoys being acquainted with new cultures and trends. She loves to sing and has also lent her voice to a few short films as a playback singer. She is also trained in Indian dance forms, which she feels keeps her connected to her roots. Sneha loves to try out new cuisines and try her hands at cooking every once in a while.

Sneha believes in the idea of translational research with direct bench-to-bedside significance, and with her cumulative experience, would like to contribute to create a positive impact in the global healthcare space.

Senior Associate Consultant

Barney Poznansky

Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.

He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.

As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.  

Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research. 

Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.

Senior Associate Consultant

Emer Murphy

Emer contributes deep scientific expertise to the Eradigm team, where in her prior role she worked as a scientist on early-stage drug discovery projects with the CRUK-Astra Zeneca drug discovery alliance. This work included strategic planning of accelerated projects, managing external collaborations, and identifying new potential targets for immunooncology assets. 

Emer’s has a BSc. in Human Genetics from University College Cork, Ireland, where her focus aimed to identify the heritability of Psychosis disorders. Following this, she went on to complete an MSc. in Molecular Medicine from the University of Leeds. In her Master’s research, Emer investigated the effect of a novel small molecule inhibitor in comparison to, and in combination with, standard of care chemotherapy in childhood Ewing’s Sarcoma on primary samples from St James University Hospital in Leeds. 

Outside of work, Emer enjoys cooking, writing her food blog, making her way through the best restaurants in London and running in Victoria Park to counteract all of that. Emer enjoys reading Scandi Noir novels, while trying to keep her houseplants alive.  

Senior Associate Consultant

Guglielmo Bruni Roccia

Guglielmo joined Eradigm in February 2022 as an Associate Consultant, bringing to the team his curiosity for the life sciences and passion for global healthcare.

In his previous role, Guglielmo worked in consulting projects spanning therapeutic areas including oncology, rare diseases, and women’s health. He was involved in advising clients with their growth strategy, by identifying assets for potential acquisition to expand their drug portfolio. Guglielmo also focused on competitive intelligence (CI) projects, where he monitored competitor’s clinical trial developments, product launch timelines and marketing strategies, to help clients, understand their competitive environment and the opportunities and challenges it presents. He also gained relevant experience while working for the Luxembourg Institute of Health where he was part of a team developing a drug monitoring device for patients with chronic conditions. 

Guglielmo studied for an MSc in Drug Discovery and Pharma Management at University College London (UCL), where he gained a holistic understanding of the regulatory and commercial aspects of drug development. His master’s thesis focused on the unmet needs of in vitro fertilisation and the emerging innovative solutions. He holds a BSc in Neuroscience from the University of Sussex with an integrated exchange academic year at the Nanyang Technological University in Singapore. 

In his free time, Guglielmo is an avid runner and tennis player. He also fosters a deep enthusiasm for classical music, having been playing the violin since he was 6 years old. Passionate about exploring new cultures, Guglielmo enjoys travelling around the world, meeting new people, and experiencing local cuisines.

Senior Associate Consultant

Jada Mejia

Jada joined Eradigm in March 2022 as an Associate Consultant. She brings extensive pharmaceutical market research experience and a passion for global healthcare. In her previous role, she focused on primary and secondary quantitative research, designing surveys aimed at HCPs and consumers whilst also creating client deliverables that answer their main research objectives. 

Jada holds a Bsc. in Health Sciences with a specialisation in Policy, Management and Evaluation of Healthcare from Maastricht University in the Netherlands. During her Bsc. Jada did a 6-month exchange programme at McMaster University in Canada, where she further developed her global healthcare knowledge by undertaking several Canadian healthcare courses. Jada’s curiosity and passion to help improve healthcare systems led her to pursue an Msc. degree in Health Economics, Policy and Law at Erasmus University in Rotterdam, the Netherlands. For her final research project Jada conducted a quantitative survey focussing on whether healthcare rationing occurs amongst GPs in Aruba. 

Being born and raised in Aruba before moving to the Netherlands at 18, Jada has been fortunate enough to explore a variety of different cultures and languages. Jada is fluent in Dutch, Papiamento and English, has intermediate level Spanish and is keen to learn British Sign Language. Prior to academia, Jada formed part of the Aruban Taekwondo National Team, competing in different national and international championships. Outside of work, Jada enjoys going to the gym, watching films, singing and hanging out with friends. 

Associate Consultant

Shreya Murali

Shreya joined Eradigm in April 2021 as an associate consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.

Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.

Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.

In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.

Senior Associate Consultant

Oliver Odell

Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.

Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.

Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.

Senior Associate Consultant

Nadeen Solaiman

Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.

Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.

Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.

Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.  

Senior Associate Consultant

Paula Wegbrans Giro

Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.

Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.

Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.

Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.

Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people. 

Senior Associate Consultant

Aalia Jawad

Focus Therapy Areas: Neurology, Rare Diseases, Infectious Diseases

Specialist Expertise: Pricing Strategy, Market Access Strategy, Landscape Assessments, Demand Forecasting, Payer Research, Country Prioritization, Launch Sequencing, and Market Research

Education: BSc (Hons) Biomedical Science, University of Edinburgh. Aalia holds a Lean Six Sigma Green Belt from the University of Oxford

What is your focus at Eradigm?

I use my analytical background and previous consulting experience to support biopharma companies solve their most fundamental challenges throughout the market access and ensure patients can access new treatments

Who do you work with?

I largely collaborate with commercial, value, and access teams and market research teams at Big Pharma and small to mid-size biotech companies

What is your specialist expertise, and what types of projects do you work on?

Aalia’s expertise spans Market Access Strategy, particularly in pricing analysis, demand forecasting, and launch sequencing using secondary research and payer interviews to inform strategic decision making

What did you do before Eradigm?

Prior to joining Eradigm, Aalia supported multiple projects in life sciences and across financial services and consumer goods across commercial strategy, organizational strategy and operating model design, process re-engineering and operational excellence, supply chain analysis, cost optimisation, and EBITDA improvement

What are your passions outside of work?

Outside of work, Aalia is an enthusiastic cook and enjoys experimenting with new flavours and cultures. In her spare time, you can find her exploring London’s newest restaurants, spending time with her family, and trying to keep her plants alive

Associate Consultant

Zain Aziz

Zain joined Eradigm in May 2022 as an Associate Consultant bringing to the team his curiosity for the life sciences and passion for global healthcare.

Prior to joining Eradigm, Zain has worked in consulting projects with different healthcare providers across Europe aiding in their digital transformation process and the implementation of electronic patient healthcare record systems. His focus was mainly within clinical research organisation, and he was heavily involved with advising clients as to how to identify potential opportunities to increase recruitment onto clinical studies, as well as increasing patient study visibility for trust members, with the end goal to provide better overall care for patients being treated.

Zain holds a BSc and PhD in Biomedical Sciences and Biotechnology, respectively from the University of Westminster. His research was focused on the development of novel fermentation strategies to increase the production of bioplastics through the manipulation bacterial communication circuits. During his PhD, Zain was also able to acquire a professional development qualification in learning and teaching within the
Higher Education Academy, U.K.

Outside of work, Zain is an avid hiker and frequent gym-goer who loves to travel and visit new places. In his free time, he enjoys exploring London’s live music offerings and carrying out DIY projects.

Senior Associate Consultant

Kelly Choong

Kelly joined Eradigm in June 2022 as an Associate Consultant, bringing to the team her experience in medical communications and scientific publishing, and her passion for advancing healthcare research. 

Kelly previously worked in medical communications as an Account Executive, where her role largely involved project and client management. She worked with pharmaceutical companies on a range of projects related to Medical Affairs, which were used to train field medical teams in the Respiratory and Infections department. Prior to this, Kelly worked at an open access scientific publisher as a Journal Launch Specialist. This role involved extensive liaison with academics and building editorial boards. As a result, she launched two new journals in Engineering and Health Sciences, and multiple sections within existing journals. 

Kelly completed both her BSc and MScR at Durham University in Biomedical Sciences. Her master’s thesis in Tissue Engineering was titled ‘Investigating the deposition of the extracellular matrix and bone tissue development in vitro using 2D and 3D cell culture methods’. The laboratory-based study investigated the use of a 3D scaffold to culture bone forming cells, in order to develop an in vitro bone tissue model which could then ultimately be used to model diseases such as osteoporosis. Kelly gained extensive experience in the lab, learning techniques such as mammalian cell culture, histology and stem cell differentiation.  

Outside of work, Kelly likes to cook and experiment with new recipes. She is always on the lookout for new restaurants to try and welcomes any recommendations. She enjoys exploring nature and watching sitcoms in her free time. 

Senior Associate Consultant

Liam Maddison

As Liam joins Eradigm in July 2022 as an Associate Consultant, he brings a wealth of early-stage therapeutic discovery expertise following the completion of his industry-partnered PhD programme. He has a keen interest in the application of disruptive technologies within the healthcare landscape and a desire to work with key stakeholders to revolutionise current treatment paradigms.

Undertaking his PhD research at The University of Leeds, Liam spearheaded an early-stage drug discovery campaign against a prominent epitranscriptomic regulator, with the promise to meet unmet needs in oncology and virology. The project identified a collection of novel hits against the target, culminating in the development of a potent lead compound that will be the subject of further optimisation, laying the groundwork for therapeutic development. Throughout this project, Liam managed a multi-centre collaboration and worked closely with scientists and leadership at his pharmaceutical partner company.

During his PhD studies, Liam nurtured a growing interest in the commercial aspects of the Life Sciences sector, competing in national entrepreneurship competitions and securing freelance consulting work to enhance his skillset. Here, he worked alongside top 20 pharma clients to hone his CI skills, conducting market research and conference monitoring across the cell therapy and HIV landscapes.

Prior to this, Liam completed an integrated master’s degree in Medicinal chemistry at the University of Leeds, where he discovered an interest in the pharmaceutical industry and developed expertise in small molecule drug development.

In his free time, Liam enjoys getting outdoors as much as possible, whether that be backpacking, hiking or trail running. When not out in nature, you will most likely find him anxiously watching Newcastle United, listening to his vinyl record collection, or kicking back with a good book.

Associate Consultant

Kamaal Lynch-Samms

Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.

He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.

During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.

In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.

Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.

Senior Associate Consultant

Sean Abbott-Imboden

Sean joined Eradigm as an Associate Consultant in August 2022, bringing to the team his prior experience in healthcare consultancy, medical communications and data management.

Sean previously worked at a boutique life sciences consulting firm, where his role centred on conducting primary and secondary research to identify key market events and trends to support pharmaceutical companies’ strategy. Sean has worked with a plethora of pharmaceutical companies across a range of therapeutic area specific projects and cross-portfolio workstreams. Prior to this, Sean worked in Data Management for a top-10 clinical research organisation where he was responsible for reconciling and analysing clinical trial data, maintaining study documentation, and performing quality control audits of clinical trial databases.

Sean holds a BSc in Biomedical Sciences from the University of Warwick which provided him with a platform to pursue his MSc in Cancer Biology at University College London (UCL). His MSc (Distinction) consolidated his skills in critically evaluating primary and secondary scientific literature, experimental planning and interpretation of results. Diverging away from his oncology background to supplement his knowledge and support broader research efforts, his MSc dissertation focused on developing a computational in-silico model to identify drug combinations to fight COVID-19. His work contributed to a scientific publication in Nature Partner Journals – Digital Medicine.  

Sean’s academic and professional experiences have provided him with a deep understanding of the commercial and therapeutic landscape across oncology, neurology and COVID-19 as well as continually emerging fields such as digital healthcare.

Outside of work, Sean is a huge sports enthusiast. He is particularly keen on playing football, running, going to the gym and skiing. He also enjoys travelling and spending time with friends and family.

Senior Associate Consultant

Adama Anozie

Focus Therapy Areas: Rare Diseases & Orphan Drugs, Oncology, Cell Therapies

Specialist Expertise: Pricing & Market Access Strategy, Landscape Assessments, Value-Based Messaging, Medical Strategy

Education: MSc Drug Discovery & Pharma Management, University College London; BSc Pharmacy, University of Manitoba; BSc Pharmacology, McGill University

What is your focus at Eradigm?

I use my robust analytical and clinical background to help clients understand and develop their global pricing, reimbursement, and market access strategy. I work as part of Eradigm’s Market Access and Medical Strategy teams to comprehensively conduct high-quality research, analyse insights, and deliver impactful, actionable recommendations for our clients.

Who do you work with?

I typically work with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies in global pricing and reimbursement strategy, with a focus on rare diseases and orphan drugs in the UK and EU. I work cross-functionally, developing and delivering targeted and impactful recommendations to help clients understand market landscapes and pricing dynamics across the UK, EU, and Japan. Key capabilities include landscape mapping, global primary research with payers and stakeholders, price and revenue forecasting, and value messaging development

What did you do before Eradigm?

Prior to Eradigm, I worked on developing PRMA strategy for clients across the UK, EU, and US. I was involved in consulting projects helping clients understand pricing and revenue potential by conducting and analysing primary research, as well as building price and revenue modelling tools accounting for country-specific Health Technology Assessment and reimbursement systems, client and competitor strategy, and launch sequencing

What are your passions outside of work? Outside of work, I can usually be found in or adjacent to a bakery. I also enjoy playing football, visiting art exhibitions, watching anime, and creating playlists for extremely specific moments of life

Associate Consultant

Isaac Bryan

Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research. 

In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.

Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk. 

Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.

Associate Consultant

Joshua Wyatt

Joshua joined Eradigm in September 2022 as an Associate Consultant, bringing his relevant academic and professional experience alongside.

Joshua holds an Honours BSc from the University of Toronto in Canada, from a joint program with the School of the Environment and the Department of Pharmacology and Toxicology within the Faculty of Medicine. Here, Joshua discovered his interest in chemical pollutants, antibiotic resistance, and climate change. In the midst of his undergrad, Joshua participated on an academic exchange to the University of Amsterdam, Netherlands, where he gained a global view on the pharmaceutical industry. Further his studies, Joshua went forth to complete a Masters degree in Drug Discovery and Pharma Management at the UCL School of Pharmacy in London, England. In his dissertation, Joshua studied the recent trends in Alzheimer’s disease drug development and clinical trial research, and discovered important findings in the commercial operations of the neurodegenerative disease space.

Alongside his undergraduate studies, Joshua worked at a small toxicological research organization, contributing to reports and datasets on various chemicals around the globe, and how they bioaccumulate within different species and their food systems. Alongside his graduate dissertation, Joshua worked an internship with Clarivate Analytics, where he learned a vast amount about life science consulting, and the various projects, deliverables, and resources many different companies require to advance their pipeline and revenue.

Outside of academia and work, Joshua coached local swim teams and helped organize community events around Toronto, making great friends and memories along the way. In his spare time, Joshua loves to cycle around the countryside, play basketball with friends, and practice his musical instruments.